At the 11th IVD Industry Summit Forum, Zhu Yaoyi, President of IVD branch of China Medical Device Industry Association, pointed out that with the improvement of medical system reform and medical level, Chinese medical device IVD industry is developing towards high standard, high efficiency and intelligence with an increasingly open and integrated attitude. Xia Wenlong, Shandong from food and Drug Certification Center said that, the research on the stability of reagents (especially the stability of opening bottles and the stability of re solution) should fully consider the adverse conditions in actual storage, transportation and use, and carry out the corresponding research, and make a profound analysis on the data statistics and document standardization of the trial scheme in clinical verification.Huang Jie, a researcher of China food and drug inspection, pointed out that the general direction of product innovation should be advanced. For multi-field integration, we should pay attention to the intelligence and automation of the products, and the products should meet the clinical needs as much as possible, and the products should be positioned and classified, such as screening, auxiliary diagnosis, prediction, target drug selection, treatment monitoring, etc.

Mass Spectrometry in China - YingSheng  

Yingsheng biology, as a leader in the field of mass spectrometry detection in China, participated in the event and brought the "fully auto intelligent clinical mass spectrometry one-stop program" independently developed by Yingsheng biology. Yingsheng once again made great achievements in the exhibition, attracting agents from Shandong, Hebei, Shanxi, northeast provinces and other regions to the booth for in-depth communication. The products included: high-throughput automatic sample pretreatment system (ys-600), high performance liquid chromatography tandem mass spectrometry detection system (YS ext 9050 MD), inductively coupled plasma mass spectrometry detection system (YS ext 8600) and other instruments

The IVD exhibition hall where Yingsheng biology is located has attracted much attention. It is not hard to find from the performance of many enterprises. At present, the development direction of IVD in China has been toward the direction of more and more complete projects, higher and higher degree of automation, more and more intimate product operation, more and more accurate detection projects. At present, Yingsheng biology has developed from the initial deafness gene detection, newborn genetic metabolic disease screening, full spectrum 14 vitamin detection to the project that can detect free fatty acids, bile acids and amino acids, etc. the precision detection projects carried out by tandem mass spectrometry are increasing everyday, which also respond to the strategic situation of precision medicine in China in a timely manner. Secondly, Yingsheng biology's full spectrum The automatic multi-functional sample pre-processing system can make the mass spectrometry detection enter the automatic era, and avoid the influence of objective factors on the experimental results and the influence of the chemical reagents used in the detection on the experimental operators.

Yingsheng biology has been committed to the development of clinical mass spectrometry detection technology, is a high-tech enterprise integrating R & D, production, sales and third-party medical detection services. At present, around metabonomics and genealogy, a leading domestic gene detection platform and mass spectrometry detection platform have been set up, which is the backbone enterprise of Shandong Province's key biomedical engineering industry cluster. At present, it has carried out strategic cooperation with thermofisher of the United States, Hamilton of Switzerland, labsystems of Finland, trivitron of India, biotechnology of Sweden and other international well-known companies; it has always followed the concept that the demand comes from the clinical, product service to the market, centered on the "life cycle, the whole process of health", and has continued to closely contact with such advantageous units as the Chinese Academy of Sciences, Zhongshan University, medical institutions, etc. Make, innovate and surpass.